Drug application
NYSTATIN (NYSTATIN)
Drugs@FDA ANDA 062065 · SANDOZ
Key facts
| Drug name | NYSTATIN |
|---|---|
| Active ingredients | NYSTATIN |
| Application type | ANDA |
| Application number | 062065 |
| Company | SANDOZ |
| Dosage forms | TABLET, ORAL |
| Strength | 500,000 UNITS |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Sep 16, 1994 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.